"An important aim of our research is to develop novel vaccines and antivirals against influenza. For this we focus on the influenza A virus M2 protein and neuraminidase. We are particularly interested in the protective mechanisms of action of such novel influenza vaccines. We are also developing novel antibody-based therapeutics against influenza viruses as well as broadly neutralizing antibody-based biologics against betacoronaviruses.

In addition, we aim to elucidate the antiviral mechanism of action of the interferon-induced virus restriction factors Mx1 and Mx2 by making use of interactomics."